Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
09/03/2003 | EP1185237B1 Synergistic antibacterial combination |
09/03/2003 | EP1140187B1 Combinations of an ibat inhibitor and a mtp inhibitor for cardiovascular indications |
09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
09/03/2003 | EP0910372B1 Pharmaceutical compositions containing mesembrine and related compounds |
09/03/2003 | EP0815831B1 Dentifrice composition |
09/03/2003 | EP0772447B1 Chinese herbs extract |
09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
09/03/2003 | CN1119989C Cosmetic compositions for skin and/or hair photoprotection which are based on sinergic mixture of filters and use thereof |
09/03/2003 | CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition |
09/03/2003 | CN1119987C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition |
09/03/2003 | CN1119985C Cosmetic composition including acrylic anionic polymer and oxyalkylene silicone |
09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
09/02/2003 | US6613102 As thickening polymer nonionic guar gums; biopolysaccharide gums of microbial origin; |
09/02/2003 | CA2216796C Quinazoline derivatives |
08/28/2003 | WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates |
08/28/2003 | WO2003070246A1 Controlled synthesis of ziprasidone and compositions thereof |
08/28/2003 | US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol |
08/28/2003 | US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
08/28/2003 | US20030162749 Use of cdp-choline for the treatment of alcohol withdrawal syndrome |
08/28/2003 | US20030162184 Amplification; polymerase chain reactions |
08/28/2003 | US20030161867 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
08/28/2003 | US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents |
08/27/2003 | EP1337279A1 Sterilisation of pharmaceuticals |
08/27/2003 | EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
08/27/2003 | CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents |
08/27/2003 | CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists |
08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
08/26/2003 | US6610665 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives |
08/26/2003 | US6610332 Antiprotozoa agents; plant extracts |
08/26/2003 | US6610279 Emulsions with naphthalate esters |
08/21/2003 | WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors |
08/21/2003 | WO2003068722A1 Carboxylic acid compounds for use as surfactants |
08/21/2003 | WO2003068193A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation |
08/21/2003 | WO2003068145A2 Herbal immune system stimulant |
08/21/2003 | WO2003032893A3 Assignment |
08/21/2003 | WO2002102308A3 Pharmaceutical composition for the treatment of viral infection |
08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
08/21/2003 | US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death |
08/21/2003 | US20030158210 Amino acid ester containing azole antifungals |
08/21/2003 | US20030158206 Sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders. |
08/21/2003 | US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
08/21/2003 | US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis |
08/21/2003 | US20030157032 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
08/21/2003 | US20030156972 Irradiation of ispaghula |
08/21/2003 | CA2475659A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation |
08/21/2003 | CA2474626A1 Carboxylic acid compounds for use as surfactants |
08/20/2003 | EP1336413A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
08/20/2003 | EP1335740A1 Method and preparations having effect against allergic symptoms |
08/20/2003 | EP1075258B1 Novel fatty analogues for the treatment of obesity |
08/20/2003 | EP0966295B1 Calcareous material |
08/20/2003 | EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin |
08/20/2003 | CN1118571C Active protein with thrombopoietin |
08/19/2003 | US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
08/19/2003 | US6608033 Treatment or prevention of coccidiosis |
08/19/2003 | US6607784 Microprecipitation method for preparing submicron suspensions |
08/19/2003 | US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
08/19/2003 | CA2012414C Hog cholera virus vaccine and diagnostic |
08/14/2003 | WO2003065993A2 Primary rat hepatocyte toxicity modeling |
08/14/2003 | WO2003065990A2 Stenoprophiluric generation and isolation of chemical products |
08/14/2003 | WO2003032973A3 Composition comprising paracetamol and a bitterness masking component |
08/14/2003 | WO2002024145A9 Antiviral substances from plant cuticular and epicuticular material |
08/14/2003 | US20030153757 Synthesis and purification of valacyclovir |
08/14/2003 | US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
08/14/2003 | US20030153544 Fatty acid derivatives |
08/14/2003 | US20030153065 A formulation for maintaining a non-enveloped viral vector containing: trehalose, magnesium chloride, a cationic polymer or a combination, a multiple of non-enveloped viral vector particles and a liquid carrier |
08/14/2003 | US20030153046 Interferon gamma conjugates |
08/14/2003 | US20030152912 Multiple viral replicon culture systems |
08/14/2003 | US20030152535 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent |
08/14/2003 | CA2474918A1 Stenoprophiluric generation and isolation of chemical products |
08/14/2003 | CA2471631A1 Primary rat hepatocyte toxicity modeling |
08/13/2003 | EP1334727A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
08/13/2003 | EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration |
08/13/2003 | EP1334363A2 Platelet/leukocyte interaction assay and reagent therefor |
08/13/2003 | EP1333805A2 Cosmetic method of treating skin |
08/13/2003 | EP1132090B1 Method for producing an agent for treating ulcers of the organism |
08/13/2003 | EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
08/13/2003 | EP0987269B1 Salts of optically active sulfoxide derivative |
08/13/2003 | EP0979083B1 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
08/13/2003 | EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
08/13/2003 | CN1436189A Non-nucleoside reverse transcriptase inhibitors |
08/13/2003 | CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
08/13/2003 | CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof |
08/13/2003 | CN1117732C Noval Dihydronaphthalene compound and process for producing same |
08/13/2003 | CN1117558C Compositions contg. antifungal and sulfur compound |
08/12/2003 | US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form. |
08/12/2003 | US6605601 Hypotensive agents; cardiovascular disorders |
08/12/2003 | CA2296373C Composition and method for treating penile erectile dysfunction |
08/12/2003 | CA2286126C Pharmaceutical compositions |
08/07/2003 | WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
08/07/2003 | WO2003063842A1 Composition for inhalation |
08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
08/07/2003 | WO2003063783A2 Multiple virus replicon culture systems |
08/07/2003 | WO2003063773A2 Differentially-regulated prostate cancer genes |
08/07/2003 | US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
08/07/2003 | US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis |
08/07/2003 | US20030149065 Arylkylamine spirofuropyridines useful in therapy |
08/07/2003 | US20030148964 Single dose azithromycin |
08/07/2003 | US20030147926 Compositions and methods for transdermal oxybutynin therapy |
08/07/2003 | US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides |
08/07/2003 | US20030146145 Mesoporous permeation layers for use on active electronic matrix devices |